Preview Mode Links will not work in preview mode

Jan 5, 2022

Featuring perspectives from Dr Stephen Liu, including the following topics:

  • Introduction (0:00)
  • Adjuvant and Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer (NSCLC) (1:18)
  • Case: A man in his late 50s with metastatic NSCLC and no actionable mutations — Sandip Patel, MD (19:53)
  • Case: A woman in her mid-60s with newly diagnosed adenocarcinoma of the lung — PD-L1 65% — Raji Shameem, MD (27:05)
  • Case: A man in his early 70s with localized NSCLC and no actionable mutations — PD-L1 90% — Kapisthalam (KS) Kumar, MD (33:16)
  • Case: A woman in her early 60s with extensive-stage small cell lung cancer — Ranju Gupta, MD (36:28)
  • Thoughts for the Future: Part 1 (41:17)
  • Case: A woman in her early 70s with Stage IIIB adenocarcinoma of the lung and an EGFR L858R tumor mutation — PD-L1 40% — Matthew Gubens, MD, MS (45:01)
  • Thoughts for the Future: Part 2 (51:30)

CME information and select publications